AMBELVIST 0.1 mmol/ ml sol inj 257.9 mg 65 ml

7680704410010 CH-70441 V08CA13 14.02.0.

No images available

Details

Product number
7044101
CPT
-
Packaging group
65
Unit
ml
Composition
gadoquatranum 257.9 mg, corresp. 0.1 mmol corresp. gadolinium 62.9 mg, calcobutrolum, natrii chloridum, trometamolum, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 1 ml corresp. natrium 1.235 mg.

Articles (1)

Ambelvist 0.1 mmol/ ml, Injektionslösung in einer Flasche
Injektionslösung
65
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
gadoquatranum
257.9 MG Substance Wirkstoff (Principe actif)
gadolinium
62.9 MG Substance WIIS
calcobutrolum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
trometamolum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.235 MG Substance HBESI

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
70441
Drug name
Ambelvist, Injektionslösung in einer Flasche
Galenic form
LSINJ
ATC Code
V08CA13
Authorization status
Z
Dispensation category
B
First authorization
28/08/2026
Authorization expiration date
27/08/2031
IT number
14.02.0.
Domain
Human medicine
Field of application
MRT-Kontrastmittel für die ZNS-Diagnostik und weitere Körperregionen

Packaging details

Description (FR)
AMBELVIST 0.1 mmol/ ml sol inj 257.9 mg 65 ml
Description (DE)
AMBELVIST 0.1 mmol/ ml Inj Lös 257.9 mg 65 ml
Market launch
01/11/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data